BioSpace News Archive

Drug Development

ADC Therapeutics Announces First Patient Dosed in Phase I Clinical Trial of ADCT-601 in Advanced Solid Tumors

Pyrrolobenzodiazepine-based antibody drug conjugate targets AXL, a receptor tyrosine kinase highly expressed in solid tumors

January 17, 2019
·
3 min read
Business

OKI and ARC Innovation Center at Sheba Join Forces to Prevent Dementia

Aiming at a service which prevents dementia and enables a society of healthy longevity

January 17, 2019
·
4 min read
Policy

Capitol Hill Sees a Burst of Activity Over Potential Drug Pricing Control Legislation

U.S. federal lawmakers are discussing various legislative plans that could lower the out-of-pocket expenses many Americans pay for their medications. The plans are coming from both chambers of Congress and with a divided government, lines in the sand will likely be drawn.

January 17, 2019
·
3 min read
·
Alex Keown
Business

Two Malaysian Companies to Develop Breakthrough Low GI Roti Canai

Food ingredient specialist Holista CollTech Ltd (ASX:HCT, “Holista”) has partnered Bursa Malaysia-listed Kawan Food Berhad (“Kawan Food”) to produce healthy Asian flatbreads, including roti canai, roti and chappati, for local and international markets.

January 17, 2019
·
3 min read
Business

Dental Biomaterials Market to Grow at a CAGR of 4.4% through 2026

The growing edentulous population is expected to be an important factor driving the growth of the global dental biomaterials market throughout the forecast period as people aged 60 years and above are at a high risk of developing dental disorders

January 17, 2019
·
3 min read
Ongoing restructuring of ASIT biotech organization to maximize the success of gp-ASIT+™ in grass pollen rhinitis

Reflecting the shareholders’ decisions, Michel Baijot is now leading the company as new CEO towards its reassessed strategic goals for 2019 and onwards

January 17, 2019
·
6 min read
Business

Spectrum Pharma Sells Marketed Portfolio of 7 Drugs to Acrotech for $300 Million

Acrotech Biopharma, a New Jersey-based subsidiary of Aurobindo Pharma USA, is buying Henderson, Nevada-based Spectrum Pharmaceuticals’ seven FDA-approved hematology/oncology products.

January 17, 2019
·
3 min read
·
Mark Terry
FDA

FDA Committee Votes 18-1 for Amgen’s Osteoporosis Drug

This follows a 2017 rejection by the agency, requesting more data. As Jefferies analyst Michael Yee wrote in a note to clients, Amgen is “back in the game.”

January 17, 2019
·
3 min read
·
Mark Terry
Drug Development

January 18 Research Roundup: Skin Cancer, Turning Cancer Cells Into Fat Cells, and a Longevity Test

There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.

January 17, 2019
·
6 min read
·
Mark Terry
Business

Adocia confirms its financial calendar for 2019

Adocia confirmed its financial calendar for 2019 with a change in date of the annual shareholder’s meeting.

January 17, 2019
·
4 min read